The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: A Summary and Comparison With Other Recent Clinical Practice Guidelines

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Headache

• Publication date

  2012-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1526-4610.2012.02185.xPMID 22671714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses

  2012cited by this paper
• Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults

  2012cited by this paper
• Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: [RETIRED]

  2012influential reference
• Understanding why evidence from randomised clinical trials may not be retrieved from Medline: comparison of indexed and non-indexed records

  2012cited by this paper
• Out of sight but not out of mind: how to search for unpublished clinical trial evidence

  2012cited by this paper
• Impact of document type on reporting quality of clinical drug trials: a comparison of registry reports, clinical study reports, and journal publications

  2012cited by this paper
• 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia

  2012cited by this paper
• Missing clinical trial data

  2012cited by this paper
• Canadian Headache Society guideline for migraine prophylaxis.

  2012cited by this paper
• Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators

  2012cited by this paper
• Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register

  2011cited by this paper
• Quality varies across clinical practice guidelines for mammography screening in women aged 40-49 years as assessed by AGREE and AMSTAR instruments.

  2011cited by this paper
• Guidelines on the diagnosis and the current management of headache and related disorders

  2011cited by this paper
• Subcutaneous sumatriptan: results of a peculiar, unpublished, comparative, double-blind, randomised, and controlled trial

  2011cited by this paper
• Vascular risk factors, endothelial function, and carotid thickness in patients with migraine: relationship to atherosclerosis.

  2010cited by this paper
• The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies

  2010cited by this paper
• Patient and practitioner noncompliance: rationing, therapeutic uncertainty, and the missing conversation

  2010cited by this paper
• Neurobiological and psychiatric consequences of child abuse and neglect.

  2010cited by this paper
• Microemboli may link spreading depression, migraine aura, and patent foramen ovale

  2010cited by this paper
• Headache and biomarkers predictive of vascular disease in a representative sample of US children.

  2010cited by this paper
• AGREE II: advancing guideline development, reporting and evaluation in health care

  2010cited by this paper
• AGREE II: advancing guideline development, reporting, and evaluation in health care.

  2010cited by this paper
• Childhood Maltreatment and Migraine (Part II). Emotional Abuse as a Risk Factor for Headache Chronification

  2010cited by this paper
• Relationship Between Childhood Physical Maltreatment and Migraine in Adolescents

  2010cited by this paper
• AGREE II: advancing guideline development, reporting and evaluation in health care.

  2010cited by this paper
• Adverse Childhood Experiences and Frequent Headaches in Adults

  2010cited by this paper
• Investigating the Association Between Childhood Physical Abuse and Migraine

  2010cited by this paper
• Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke.

  2010cited by this paper
• Unpublished clinical trials with sumatriptan.

  2009cited by this paper
• Migraine and cardiovascular disease: systematic review and meta-analysis

  2009cited by this paper
• Adverse events in randomized trials: neglected, restricted, distorted, and silenced.

  2009cited by this paper
• Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers.

  2009cited by this paper
• Migraine and Biomarkers of Endothelial Activation in Young Women

  2009cited by this paper
• Cumulative Childhood Stress and Autoimmune Diseases in Adults

  2009cited by this paper
• Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse

  2009cited by this paper
• Migraine frequency and risk of cardiovascular disease in women

  2009cited by this paper
• EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force

  2009cited by this paper
• Outcome reporting in industry-sponsored trials of gabapentin for off-label use.

  2009cited by this paper
• [Treatment guidelines for preventive treatment of migraine].

  2008cited by this paper
• Do guidelines for the diagnosis and monitoring of diabetes mellitus fulfill the criteria of evidence-based guideline development?

  2008cited by this paper
• What should clinicians do when faced with conflicting recommendations?

  2008cited by this paper
• The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma.

  2008cited by this paper
• Evaluation and Registration of Adverse Events in Clinical Drug Trials in Migraine

  2008cited by this paper
• The fragile mind: early life stress and inflammatory disease.

  2008cited by this paper
• Erratum: Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American Migraine Prevalence and Prevention study (Headache (2007) 47, (355-363))

  2007cited by this paper
• Migraine prevalence, disease burden, and the need for preventive therapy

  2007cited by this paper
• Proinflammatory Cytokines, Adhesion Molecules, and Lymphocyte Integrin Expression in the Internal Jugular Blood of Migraine Patients Without Aura Assessed Ictally

  2006cited by this paper
• Patterns of Diagnosis and Acute and Preventive Treatment for Migraine in the United States: Results from the American Migraine Prevalence and Prevention Study

  2006cited by this paper
• Improvement in Quality of Life and Activity Limitations in Migraine Patients after Prophylaxis. A Prospective Longitudinal Multicentre Study

  2006cited by this paper
• An independent AGREE evaluation of the Occupational Medicine Practice Guidelines.

  2006cited by this paper
• Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress.

  2006cited by this paper
• Endocrine Function Is Altered in Chronic Migraine Patients with Medication‐Overuse

  2006cited by this paper
• Evidence Based Guidelines for Treatment of Primary Headaches : Report of The Croatian Neurovascular Society

  2005cited by this paper
• Cost‐Effectiveness of Topiramate in Migraine Prevention: Results From a Pharmacoeconomic Model of Topiramate Treatment

  2005cited by this paper
• Menstrual migraine: timing is everything.

  2004cited by this paper
• Childhood maltreatment as a risk factor for adult cardiovascular disease and depression.

  2004cited by this paper
• Association between Adolescent Chronic Daily Headache and Childhood Adversity: A Community-Based Study

  2004cited by this paper
• Relationship between multiple forms of childhood maltreatment and adult mental health in community respondents: results from the adverse childhood experiences study.

  2003cited by this paper
• Association between childhood physical abuse and gastrointestinal disorders and migraine in adulthood.

  2003cited by this paper
• The neurobiological consequences of early stress and childhood maltreatment.

  2003cited by this paper
• Sympathetic nervous system interaction with the immune system.

  2002cited by this paper
• Neuropeptides: modulators of immune responses in health and disease.

  2002cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

  2002cited by this paper
• Physician explanations for failing to comply with "best practices".

  2001cited by this paper
• Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

  2001cited by this paper
• Neuroendocrine effects of subcutaneous sumatriptan in patients with migraine

  2001cited by this paper
• Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review)

  2000cited by this paper
• Adult health status of women with histories of childhood abuse and neglect.

  1999cited by this paper
• Sexual assault history and headache: five general population studies.

  1999cited by this paper
• Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.

  1999cited by this paper
• Clinical characteristics of women with a history of childhood abuse: unhealed wounds.

  1997cited by this paper
• Endothelial, haemostatic and haemorheological modifications in migraineurs.

  1996cited by this paper
• Psychopathology and early experience: a reappraisal of retrospective reports.

  1993cited by this paper
• Long‐term Medical Consequences of Incest, Rape, and Molestation

  1991cited by this paper

• EPILEPSY AND HEADACHE: CLINICAL PATTERNS, PATHOPHYSIOLOGICAL LINKS, AND COMORBIDITY

  2025cites this paper
• Changes in the Diagnosis and Treatment of Headache Disorders in the Transition From Pediatric to Adult Care: A Descriptive Case Series of 80 Patients

  2025cites this paper
• Use of neurofeedback as a non-pharmacological therapeutic resource for migraine in adolescents and young adults

  2025cites this paper
• Review of and Treatment Considerations for Migraine in Pregnancy and Postpartum

  2025cites this paper
• Evidence-based guidelines for the pharmacological treatment of migraine

  2025cites this paper
• Treatment of Persistent Headache After Normalization of CSF Pressure

  2025cites this paper
• The state of insurance coverage of calcitonin gene-related peptide-targeted medications and its impact on the implementation of the American Headache Society's 2024 consensus statement: An interrupted time-series analysis.

  2025cites this paper
• Vestibular Migraine: Challenges in Diagnosis and Management

  2025cites this paper
• Oxytocin Receptors on Calvarial Periosteal Innervation: Therapeutic Target for Post-Traumatic Headache?

  2024cites this paper
• Quality of Life in Individuals with Primary Headache Disorders: A Cross-Sectional Analysis at Tribhuvan University Teaching Hospital

  2024cites this paper
• Acupuncture for Prevention of Primary Headaches in Children and Adolescents: A Literature Overview for the Pediatric Neurologist.

  2024cites this paper
• Psychotropic Drugs Reemerging as Headache Medicines

  2024cites this paper
• Headaches and Vasculitis.

  2024cites this paper
• Nonspecific oral medications versus anti–calcitonin gene‐related peptide monoclonal antibodies for migraine: A systematic review and meta‐analysis of randomized controlled trials

  2024cites this paper
• Knowledge, attitudes, and practices of migraine management among primary health care physicians in Al-Madinah Al-Munawarah

  2024cites this paper
• The Effect of Calcitonin Gene-Related Peptide Monoclonal Antibodies on Quality of Life among Migraine Patients: Pilot Study at the Hospital of Lithuanian University of Health Sciences Kaunas Clinics

  2024cites this paper
• Ibero-American consensus statement on migraine treatment.

  2024cites this paper
• Preventive treatment of migraine: Non-specific oral agents.

  2024cites this paper
• Petasites hybridus: scientific evidence A

  2024influential citation
• Pharmacotherapies for Migraine and Translating Evidence From Bench to Bedside.

  2024cites this paper
• Concentration‐QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval

  2024cites this paper
• Epidemiological, clinical characterization and treatment patterns of migraine patients in a Colombian cohort from 2018 to 2022

  2024cites this paper
• Shared Genetics of Migraine and Gastrointestinal Disorders Implicates Underlying Neurologic Mechanisms Yet Heterogeneous Etiologies

  2024cites this paper
• Petasites hybridus in migraine prophylaxis: literature review

  2024cites this paper
• The Potential of Psychedelics for the Treatment of Episodic Migraine

  2023cites this paper
• Efficacy and Safety of Anti-CGRP Monoclonal Antibodies in Prevention of Chronic Migraine: A Bayesian Network Meta-analysis

  2023cites this paper
• Recent applications of Kampo treatment for neurological diseases

  2023cites this paper
• Conventional and unconventional treatments for migraine

  2023cites this paper
• Matching adjusted indirect comparison of acupuncture versus fremanezumab in the preventive treatment of episodic migraine

  2023cites this paper
• Bridging the gap between preclinical scientists, clinical researchers, and clinicians: From animal research to clinical practice

  2023cites this paper
• Gabapentinoid Prescribing Practices at a Large Academic Medical Center

  2023cites this paper
• The Safety of Celecoxib as an Acute Treatment for Migraine: A Narrative Review

  2023cites this paper
• Migraine in perimenopausal women

  2023cites this paper
• Managing and Preventing Migraine in the Emergency Department: A Review.

  2023cites this paper
• European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptyline

  2023cites this paper
• Approach to headache disorders and the management of migraine: consensus guidelines from the Headache Society of Singapore, first edition (2023).

  2023cites this paper
• Functional neurological seizures and migraine: A systematic review and case series.

  2023cites this paper
• Recent Developments in Vestibular Migraine: A Narrative Review.

  2023cites this paper
• Carbonation and Sweet Taste Dysgeusia with Topiramate Therapy for Migraine Prevention Treatment: a Case Report

  2023cites this paper
• Pharmacogenetics in Primary Headache Disorders

  2022influential citation
• Nutritional intake of riboflavin (vitamin B2) and migraine: a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) 2001–2004

  2022cites this paper
• Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life Study

  2022cites this paper
• Integrative Approaches to Headaches

  2022cites this paper
• Atogepant for the prevention of episodic migraine in adults

  2022cites this paper
• Psychedelics in the Treatment of Headache and Chronic Pain Disorders.

  2022cites this paper
• The disease burden of migraine patients receiving prophylactic treatments in Korea: a population-based claims database analysis

  2022cites this paper
• An Exponential Curve Relationship Between Serum Urate and Migraine: A Cross-Section Study From NHANES

  2022cites this paper
• Prolonged Post Traumatic Headache after Repetitive Sports Related Concussions

  2022cites this paper
• Comparison of Propranolol versus Amitriptyline as monotherapy for migraine prophylaxis

  2022cites this paper
• Migraine Preventive Therapy; Focus on β-blockers; Literature Review

  2021cites this paper
• InterMiG: international differences in the therapeutic approach to migraine patients in specialized headache centers

  2021cites this paper
• Vestibular and auditory manifestations of migraine

  2021cites this paper
• Preventive Migraine Treatment

  2021cites this paper
• Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study

  2021cites this paper
• Prophylaxis of Migraine Protocols and Options

  2021cites this paper
• Chiropractic student diagnosis and management of headache disorders: A survey examining self-perceived preparedness and clinical proficiency.

  2021cites this paper
• Treatment of postictal headache.

  2021cites this paper
• Migraine: integrated approaches to clinical management and emerging treatments.

  2021cites this paper
• Early Experiences in Switching between Monoclonal Antibodies in Patients with Nonresponsive Migraine in Spain: A Case Series

  2021cites this paper
• CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: A systematic review and meta-analysis

  2021cites this paper
• Percutaneous Interventional Strategies for Migraine Prevention: A Systematic Review and Practice Guideline.

  2021cites this paper
• Efficacy and Feasibility of Behavioral Treatments for Migraine, Headache, and Pain in the Acute Care Setting

  2020cites this paper
• Update in migraine preventive treatment.

  2020cites this paper
• Therapeutic role of melatonin in migraine prophylaxis: Is there a link between sleep and migraine?

  2020cites this paper
• MAGraine: Magnesium compared to conventional therapy for treatment of migraines

  2020cites this paper
• Monoclonal antibodies against calcitonin gene-related peptide in chronic migraine: an adjusted indirect treatment comparison.

  2020cites this paper
• CGRP antagonists for decreasing migraine frequency: New options, long overdue

  2020cites this paper
• Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine

  2020cites this paper
• The most common errors in current migraine prophylaxis: case reports

  2020cites this paper
• Economic burden and risk factors of migraine disease progression in the US: a retrospective analysis of a commercial payer database

  2020cites this paper
• Postconcussive Headache

  2020cites this paper
• Management of Chronic Migraine in Children and Adolescents: A Brief Discussion on Preventive Therapies

  2020cites this paper
• [Update on beta blockers in 2020].

  2020cites this paper
• Emerging Treatment Options for Migraine.

  2020cites this paper
• Serotonin–norepinephrine reuptake inhibitors for the prevention of migraine and vestibular migraine: a systematic review and meta-analysis

  2020cites this paper
• Headaches

  2020cites this paper
• Erenumab aooe: a milestone for the preventive treatment of migraine

  2020cites this paper
• Developing Strategy of Clinical Practice Guidelines for Post-intensive Care Syndrome: A Systematic Review of 14 Practice Guidelines and 10 Consensus Statements

  2020cites this paper
• Mise au point sur les bêtabloquants en 2020

  2020cites this paper
• Headache management in a Veteran population: First considerations.

  2020cites this paper
• Association between Migraine and Cryptogenic Ischemic Stroke in Young Adults

  2020cites this paper
• Profilaxis en la Migraña: Descripción de la Prescripción en un Primer Nivel de Colombia

  2020cites this paper
• Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA

  2020cites this paper
• Migraine and menopause - a narrative review

  2020cites this paper
• Different Doses of Erenumab for Preventive Treatment of Episodic Migraine: A Systematic Review and Network Meta-Analysis

  2020cites this paper
• Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions

  2019cites this paper
• Headache in the elderly.

  2019cites this paper
• Calcitonin Gene-Related Peptide (CGRP) Antagonists and Their Use in Migraines

  2019cites this paper
• What's New in the Treatment of Migraine.

  2019cites this paper
• Prevalence and factors associated with the use of primary headache diagnostic criteria by chiropractors

  2019cites this paper
• Current understanding of pineal gland structure and function in headache

  2019cites this paper
• Onabotulinumtoxin‐A in Chronic Migraine: Should Timing and Definition of Non‐Responder Status Be Revised? Suggestions From a Real‐Life Italian Multicenter Experience

  2019cites this paper
• Chronic headache treatment: can we always follow international guidelines?

  2019cites this paper
• Migraine: a major debilitating chronic non-communicable disease in Brazil, evidence from two national surveys

  2019cites this paper
• Nummular Headache: 2 Cases With Good Beta Blocker Responses and a Narrative Review

  2019cites this paper
• Dizziness after Traumatic Brain Injury: Neurological Aspects

  2019cites this paper
• β-blockers: their new life from hypertension to cancer and migraine.

  2019cites this paper
• Migraine burden and costs in France: a nationwide claims database analysis of triptan users

  2019cites this paper
• Migraine and Tension-Type Headache: Diagnosis and Treatment.

  2019cites this paper
• Headache

  2019cites this paper